Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field

Author： Williams Juliet A.  

Publisher： MDPI

E-ISSN： 2077-0383|7|3|41-41

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.7, Iss.3, 2018-03, pp. : 41-41

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signal Transduction: An Exciting Field of Investigation for Small Molecule Drug Discovery

By Halazy Serge  

Molecules, Vol. 8, Iss. 4, 2003-04 ,pp. : 349-358

MDPI

Access to resources Recommend Favorite

Diversity-Oriented Synthetic Strategies Applied to Cancer Chemical Biology and Drug Discovery

By Collins Ian   Jones Alan M.  

Molecules, Vol. 19, Iss. 11, 2014-10 ,pp. : 17221-17255

MDPI

Access to resources Recommend Favorite

Updates and Controversies in the Rapidly Evolving Field of Lung Cancer Screening, Early Detection, and Chemoprevention

By Kathuria Hasmeena   Gesthalter Yaron   Spira Avrum   Brody Jerome S.   Steiling Katrina  

Cancers, Vol. 6, Iss. 2, 2014-05 ,pp. : 1157-1179

MDPI

Access to resources Recommend Favorite

Preclinical Cancer Chemoprevention Studies Using Animal Model of Inflammation-Associated Colorectal Carcinogenesis

By Tanaka Takuji  

Cancers, Vol. 4, Iss. 3, 2012-07 ,pp. : 673-700

MDPI

Access to resources Recommend Favorite

Toxins in Drug Discovery and Pharmacology

By Peigneur Steve   Tytgat Jan  

Toxins, Vol. 10, Iss. 3, 2018-03 ,pp. : 126-126

MDPI

Access to resources Recommend Favorite